Scientific Stunt Double: How a Molecular Twin Is Changing Cancer Treatment, Research
When advanced technology and data from patients’ individual cells join forces, they can enormously expand what we know about cancer and how to treat it.
Clinical Scorecard: Scientific Stunt Double: How a Molecular Twin Is Changing Cancer Treatment, Research
At a Glance
Category Detail
Condition Cancer Key Mechanisms Molecular testing and AI for personalized treatment plans Target Population Patients with various types of cancer, including pancreatic, lung, colorectal, and breast cancer Care Setting Cedars-Sinai Cancer
Key Highlights
Molecular Twin platform creates virtual replicas of patients' cancers for tailored treatment plans. Exceptional responders in pancreatic cancer show unique genetic and immune characteristics. Molecular Twin aids in identifying resistance markers in lung cancer therapies. Research focuses on biomarkers for colorectal cancer risk and advanced disease. Study of liver metastasis in breast cancer aims to develop targeted treatments. Guideline-Based Recommendations
Diagnosis
Utilize molecular testing to identify unique cancer characteristics. Management
Personalize therapy based on molecular and genetic insights. Monitoring & Follow-up
Search for blood markers indicating treatment resistance. Risks
Monitor for potential resistance in lung cancer treatments. Patient & Prescribing Data
Patients with advanced cancer types, including those with exceptional responses.
AI-driven analysis of tumor microenvironment and molecular details to inform treatment.
Clinical Best Practices
Incorporate AI and molecular testing in cancer treatment planning. Focus on understanding tumor microenvironment interactions. Identify and monitor biomarkers for treatment resistance. References
